Cancer patients who responded to sotorasib can keep taking it in this safety follow-up study
NCT ID NCT07172919
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with advanced solid tumors who have a specific gene change (KRAS G12C) and are already doing well on sotorasib (with or without panitumumab) from a previous Amgen trial. It allows them to keep receiving the treatment while doctors monitor safety and side effects. About 14 adults who can take oral medication and have a life expectancy over 3 months may join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Leon Berard
RECRUITINGLyon, 69008, France
-
Evangelische Lungenklinik
RECRUITINGBerlin, 13125, Germany
-
Florida Cancer Specialists - Fort Myers
RECRUITINGFort Myers, Florida, 33901, United States
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRoma, 00168, Italy
-
Henry Dunant Hospital Center
RECRUITINGAthens, 11526, Greece
-
National Hospital Organization Hokkaido Cancer Center
RECRUITINGSapporo, Hokkaido, 003-0804, Japan
-
Scientia Clinical Research Ltd
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Taichung Veterans General Hospital
RECRUITINGTaichung, 40705, Taiwan
-
Theagenion Cancer Hospital
RECRUITINGThessaloniki, 54007, Greece
-
Universitaetsspital Basel
RECRUITINGBasel, 4031, Switzerland
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States